165 related articles for article (PubMed ID: 30184799)
1. Mesoporous and hollow hydroxyapatite nanostructured particles as a drug delivery vehicle for the local release of ibuprofen.
Safi S; Karimzadeh F; Labbaf S
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():712-719. PubMed ID: 30184799
[TBL] [Abstract][Full Text] [Related]
2. Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine.
Wen LX; Ding HM; Wang JX; Chen JF
J Nanosci Nanotechnol; 2006; 6(9-10):3139-44. PubMed ID: 17048529
[TBL] [Abstract][Full Text] [Related]
3. Hollow carbonated hydroxyapatite microspheres with mesoporous structure: hydrothermal fabrication and drug delivery property.
Guo YJ; Wang YY; Chen T; Wei YT; Chu LF; Guo YP
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3166-72. PubMed ID: 23706197
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyapatite hierarchically nanostructured porous hollow microspheres: rapid, sustainable microwave-hydrothermal synthesis by using creatine phosphate as an organic phosphorus source and application in drug delivery and protein adsorption.
Qi C; Zhu YJ; Lu BQ; Zhao XY; Zhao J; Chen F; Wu J
Chemistry; 2013 Apr; 19(17):5332-41. PubMed ID: 23460360
[TBL] [Abstract][Full Text] [Related]
6. Hollow mesoporous hydroxyapatite nanostructures; smart nanocarriers with high drug loading and controlled releasing features.
Munir MU; Ihsan A; Sarwar Y; Bajwa SZ; Bano K; Tehseen B; Zeb N; Hussain I; Ansari MT; Saeed M; Li J; Iqbal MZ; Wu A; Khan WS
Int J Pharm; 2018 Jun; 544(1):112-120. PubMed ID: 29678543
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous hydroxyapatite nanoparticles hydrothermally synthesized in aqueous solution with hexametaphosphate and tea polyphenols.
Zhou H; Yang M; Hou S; Deng L
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():439-445. PubMed ID: 27987729
[TBL] [Abstract][Full Text] [Related]
9. Magnetic mesoporous carbonated hydroxyapatite microspheres with hierarchical nanostructure for drug delivery systems.
Guo YP; Guo LH; Yao YB; Ning CQ; Guo YJ
Chem Commun (Camb); 2011 Nov; 47(44):12215-7. PubMed ID: 21998826
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyapatite nanorod-assembled porous hollow polyhedra as drug/protein carriers.
Yu YD; Zhu YJ; Qi C; Jiang YY; Li H; Wu J
J Colloid Interface Sci; 2017 Jun; 496():416-424. PubMed ID: 28242348
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical hollow hydroxyapatite microspheres: microwave-assisted rapid synthesis by using pyridoxal-5'-phosphate as a phosphorus source and application in drug delivery.
Zhao XY; Zhu YJ; Qi C; Chen F; Lu BQ; Zhao J; Wu J
Chem Asian J; 2013 Jun; 8(6):1313-20. PubMed ID: 23554329
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of MCM-48/hydroxyapatite composites for drug delivery: Ibuprofen incorporation, location and release studies.
Pajchel L; Kolodziejski W
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():734-742. PubMed ID: 30033308
[TBL] [Abstract][Full Text] [Related]
13. AIE luminogen bridged hollow hydroxyapatite nanocapsules for drug delivery.
Li D; Liang Z; Chen J; Yu J; Xu R
Dalton Trans; 2013 Jul; 42(27):9877-83. PubMed ID: 23689833
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of anticancer drug copper bis(8-hydroxyquinoline) in hydroxyapatite for pH-sensitive targeted delivery and slow release.
Weerasuriya DRK; Wijesinghe WPSL; Rajapakse RMG
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():206-213. PubMed ID: 27987700
[TBL] [Abstract][Full Text] [Related]
15. Sol-gel derived terbium-containing mesoporous bioactive glasses nanospheres: In vitro hydroxyapatite formation and drug delivery.
Wang X; Zhang Y; Lin C; Zhong W
Colloids Surf B Biointerfaces; 2017 Dec; 160():406-415. PubMed ID: 28965080
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of NELL-1 protein from chitosan/hydroxyapatite-modified TCP particles.
Zhang Y; Dong R; Park Y; Bohner M; Zhang X; Ting K; Soo C; Wu BM
Int J Pharm; 2016 Sep; 511(1):79-89. PubMed ID: 27349789
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured material formulated acrylic bone cements with enhanced drug release.
Shen SC; Ng WK; Dong YC; Ng J; Tan RB
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():233-41. PubMed ID: 26478307
[TBL] [Abstract][Full Text] [Related]
18. Smart soft-templating synthesis of hollow mesoporous bioactive glass spheres.
Li Y; Bastakoti BP; Yamauchi Y
Chemistry; 2015 May; 21(22):8038-42. PubMed ID: 25900326
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydroxyapatite nanoparticles on ibuprofen release from carboxymethyl-hexanoyl chitosan/O-hexanoyl chitosan hydrogel.
Liu TY; Liu TY; Chen SY; Chen SC; Liu DM
J Nanosci Nanotechnol; 2006; 6(9-10):2929-35. PubMed ID: 17048500
[TBL] [Abstract][Full Text] [Related]
20. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
